Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
Couldn't agree more on this meile ghia et al his body language is oozing with confidence and has been for months. His tone has changed as well from excitement in summer to just pure cool, calm, and collectedness now.
Thank you all for all your hard work
Patience pal, patience
https://www.theguardian.com/science/2020/dec/11/coronavirus-uk-scientists-identify-drugs-that-may-help-severe-cases
I know its already been covered but also made the guardian! Sham they couldn't give us a cheeky mention!
No worries guys thanks for all your previous research. Also worth looking at this document re speculative dates of potential timescales if we were in PRIME dicsussions. It details the SAWP agenda for 2020 (who I believe report evidence to the CHMP and communicate with companies applying for PRIME). See column with start of proceure 31 Aug - Sept 3rd, which dates seems to line up with the dates in the previous document on PRIME (section 6.3.1).
https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/dates-2020-scientific-advice-working-party-sawp-meetings-deadlines-submission-scientific-advice/eunethta-requests_en.pdf
Actually it also says the SAWP recommendation comes today on that document.
See 6.3.1 for EMA CAT recommendation (8th October) and CMPH adoption (15th October) notes. Not sure where the 16th has come from? In my understanding meeting has happened and decisions are found out for Prime on these dates?
https://www.ema.europa.eu/en/documents/agenda/agenda-cat-agenda-9-11-september-2020-meeting_en.pdf
Also apologies hold4 my wording came from deep down in the 6 months results rns not from the other two, but it is copied and pasted verbatim.
Ah thanks for that so the 15th. Knew it was sometime early October! Be interesting to see if anything comes of it.
Hi guys can anyone remember the date we were meant to hear of the outcomes of the recent EMA PRIME meetings? In my head, I have the 8th of October but I can't find the document someone posted previously. Obviously, this is just conjecture but I really feel like the wording used in the RNS today would fit in with the PRIME initiative: 'Synairgen is currently in discussions with regulatory agencies to establish the regulatory route to approval of SNG001 as a treatment for COVID-19.'
I would love to hear anyone's thoughts on this. I personally think, having read a little about PRIME and previous posts on this forum, that this would be a fantastic next step and would result in some more positive and relatively immediate news.
Vanv is this meant for AVCT thread?
You forgot to mention finding out about all the other 100+ countries we're supplying to!